Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mouna Hamel"'
Publikováno v:
Microorganisms, Vol 9, Iss 2, p 442 (2021)
Since 2015, the discovery of colistin resistance genes has been limited to the characterization of new mobile colistin resistance (mcr) gene variants. However, given the complexity of the mechanisms involved, there are many colistin-resistant bacteri
Externí odkaz:
https://doaj.org/article/066557d2958c434392485f8dabeec130
Autor:
Sophie Alexandra, Baron, Nadim, Cassir, Mouna, Hamel, Linda, Hadjadj, Nadia, Saidani, Gregory, Dubourg, Jean-Marc, Rolain
Publikováno v:
Eurosurveillance
Background France is a low prevalence country for colistin resistance. Molecular and epidemiological events contributing to the emergence of resistance to colistin, one of the 'last-resort' antibiotics to treat multidrug-resistant Gram-negative infec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0a8dd96e8be309382730e95dc750848d
https://pubmed.ncbi.nlm.nih.gov/34047270
https://pubmed.ncbi.nlm.nih.gov/34047270
Autor:
Grégory Dubourg, Sophie Alexandra Baron, Nadia Saidani, Mouna Hamel, Jean-Marc Rolain, Linda Hadjadj, Nadim Cassir
Publikováno v:
Eurosurveillance
Eurosurveillance, European Centre for Disease Prevention and Control, 2021, 26 (21), ⟨10.2807/1560-7917.ES.2021.26.21.2000022⟩
Eurosurveillance, 2021, 26 (21), ⟨10.2807/1560-7917.ES.2021.26.21.2000022⟩
Eurosurveillance, European Centre for Disease Prevention and Control, 2021, 26 (21), ⟨10.2807/1560-7917.ES.2021.26.21.2000022⟩
Eurosurveillance, 2021, 26 (21), ⟨10.2807/1560-7917.ES.2021.26.21.2000022⟩
Background France is a low prevalence country for colistin resistance. Molecular and epidemiological events contributing to the emergence of resistance to colistin, one of the 'last-resort' antibiotics to treat multidrug-resistant Gram-negative infec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad1b6873a93cc0bd03322eed502e10e5
https://hal-amu.archives-ouvertes.fr/hal-03281573/file/eurosurv-26-21-4.pdf
https://hal-amu.archives-ouvertes.fr/hal-03281573/file/eurosurv-26-21-4.pdf
Autor:
Sophie Alexandra Baron, Seydina M. Diene, Sami Khabthani, Jean-Marc Rolain, Mouna Hamel, Vicky Merhej
Publikováno v:
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2021, 65 (2), ⟨10.1128/AAC.01712-20⟩
Antimicrobial Agents and Chemotherapy, 2021, 65 (2), ⟨10.1128/AAC.01712-20⟩
Antimicrob Agents Chemother
Antimicrobial Agents and Chemotherapy, 2021, 65 (2), pp.e01712-20. ⟨10.1028/aac.01712-20⟩
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2021, 65 (2), pp.e01712-20. ⟨10.1028/aac.01712-20⟩
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2021, 65 (2), ⟨10.1128/AAC.01712-20⟩
Antimicrobial Agents and Chemotherapy, 2021, 65 (2), ⟨10.1128/AAC.01712-20⟩
Antimicrob Agents Chemother
Antimicrobial Agents and Chemotherapy, 2021, 65 (2), pp.e01712-20. ⟨10.1028/aac.01712-20⟩
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2021, 65 (2), pp.e01712-20. ⟨10.1028/aac.01712-20⟩
International audience; ABSTRACT Fosfomycin is a decades-old antibiotic, currently reused because of its activity against multidrug-resistant bacteria. Here, we used a combined in vitro/in silico approach to search for fosfomycin resistance determina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af5d07818a9a690c13992650f6ce45d8
https://hal-amu.archives-ouvertes.fr/hal-03216141
https://hal-amu.archives-ouvertes.fr/hal-03216141
Autor:
Jean-Marc Rolain, Heleni Kraniotaki, Vassiliki Papaioannou, Iris Spiliopoulou, Sophia Papagianni, Nikoletta Charalampaki, Sophia Tsiplakou, Linda Hadjadj, Nikoletta Skarmoutsou, Stylianos Chatzipanagiotou, Kimon Fountoulis, Nicholaos J. Legakis, Tilemachos Skalidis, Efstathia Perivolioti, Nikolaos Papamichalopoulos, Anastasios Ioannidis, Alexandra Baron Sophie, Maria Bournia, Mouna Hamel, Myrto Christofidou, Efthimia Petinaki
Publikováno v:
International Journal of Antimicrobial Agents
International Journal of Antimicrobial Agents, 2020, 55 (4), ⟨10.1016/j.ijantimicag.2020.105930⟩
International Journal of Antimicrobial Agents, 2020, 55 (4), ⟨10.1016/j.ijantimicag.2020.105930⟩
Introduction: In Greece, the spread of carbapenem-resistant Enterobacteriaceae in humans has led to the reintroduction of colistin as a therapeutic agent. Unfortunately, colistin resistance with different mechanisms has emerged. The present work aims
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::636e6764e706e57768740c1549172e60
https://hal-amu.archives-ouvertes.fr/hal-03150172
https://hal-amu.archives-ouvertes.fr/hal-03150172
Autor:
Mouna, Hamel1 (AUTHOR), Stylianos, Chatzipanagiotou2 (AUTHOR), Linda, Hadjadj1 (AUTHOR), Efthimia, Petinaki3 (AUTHOR), Sophia, Papagianni4 (AUTHOR), Nikoletta, Charalampaki4 (AUTHOR), Sophia, Tsiplakou5 (AUTHOR), Vassiliki, Papaioannou5 (AUTHOR), Nikoletta, Skarmoutsou6 (AUTHOR), Iris, Spiliopoulou7 (AUTHOR), Myrto, Christofidou7 (AUTHOR), Nikolaos, Papamichalopoulos8 (AUTHOR), Tilemachos, Skalidis9 (AUTHOR), Nicholaos, Legakis9 (AUTHOR), Kimon, Fountoulis9 (AUTHOR), Efstathia, Perivolioti10 (AUTHOR), Heleni, Kraniotaki10 (AUTHOR), Maria, Bournia10 (AUTHOR), Anastasios, Ioannidis2 (AUTHOR), Alexandra, Baron Sophie1 (AUTHOR)
Publikováno v:
International Journal of Antimicrobial Agents. Apr2020, Vol. 55 Issue 4, pN.PAG-N.PAG. 1p.